Sp641
COST-EFFECTIVE TESTING AND RATIONAL PHARMACOTHERAPY FOR CONSTIPATIOHN, DIARRHEA, AND PAIN
Date
May 7, 2023
Explore related products in the following collection:
Society: AGA
This session will provide evidence based practical recommendations for managing disorders of gastrointestinal functions. LIVE STREAM SESSION
This session will provide evidence based practical recommendations for managing disorders of gastrointestinal functions. LIVE STREAM SESSION
Presenter
St James's University Hospital
Tracks
Related Products
PRACTICAL APPROACH TO PATIENT WITH DIARRHEA
Review updates in management of common GI disorders including irritable bowel syndrome, use of cannabis and functional dyspepsia…
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
ENCAPSULATED MICROBIOTA TRANSPLANT THERAPY IMPROVES PARTIAL MAYO SCORES IN ULCERATIVE COLITIS AND INDUCES RAPID ENGRAFTMENT COMPARED TO PLACEBO CONTROL
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
INTRODUCTION
SOCIETY: AGA
